Richard G. Gray, MA, MSc

Articles by Richard G. Gray, MA, MSc

Richard Gray on the Safety and Efficacy of 10 Years of Adjuvant Tamoxifen

June 29th 2013

Richard G. Gray, MA, MSc, discusses results from the randomized, phase III aTTom study that examined 10 years of tamoxifen versus the more standard 5 years.

Latest Updated Articles

Richard Gray on the Safety and Efficacy of 10 Years of Adjuvant Tamoxifen
Published: June 29th 2013 | Updated:

Richard G. Gray, MA, MSc

Articles by Richard G. Gray, MA, MSc

Richard Gray on the Safety and Efficacy of 10 Years of Adjuvant Tamoxifen

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma